Use of vascular endothelial growth factor receptor...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/502 (2006.01) A61B 5/145 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2653237

The invention relates to a method for screening patients for tumor burden and the use of VEGF-R inhibitors alone or in combination with chemotherapy for the treatment of gastrointestinal, genitourinary, lymphoid and pulmonary (small cell and non-small cell) cancer patients and patients with cancers of neural crest origin having high serum or plasma LDH5 levels.

L'invention concerne un procédé permettant de cribler des patients en vue de déterminer la charge tumorale, ainsi que l'utilisation d'inhibiteurs du récepteur du facteur de croissance endothélial vasculaire (VEGF-R), seuls ou combinés à une chimiothérapie, pour le traitement de patients souffrant de cancers gastro-intestinaux, urogénitaux, lymphoïdes et pulmonaires (à petites cellules ou à non-petites cellules) et de patients atteints de cancers trouvant leur origine dans la crête neurale, lesdits patients présentant des valeurs élevées de LDH5 sérique ou plasmatique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of vascular endothelial growth factor receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of vascular endothelial growth factor receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of vascular endothelial growth factor receptor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1705576

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.